| |
Urothelial Carcinoma |
Squamous Cell Carcinoma
|
Urothelial Carcinoma with Squamous Differentiation |
| |
90 patients |
112 patients |
56 patients |
| Local recurrence
|
|
|
|
| 8 months |
15(16.6%) |
11(9.8%) |
10(17.8%) |
| 3 years
|
25(27.7%) |
27(24.1%) |
40(71.4%) |
| 5 years |
30(33.3%) |
19(17%) |
6(10.7%) |
| |
|
|
|
| Metastases with or without local recurrence |
|
|
|
| 8 months
|
10(11.1%) |
11(9.8%) |
12(21.4%) |
| 3 years |
30(33.3%) |
45(40.1%) |
47(84%) |
| 5 years |
40(44.4%) |
36(32.1%) |
|
|
|
|
|
| Survival |
|
|
|
| 8 months |
85(94.4%) |
102(91%) |
48(85.9%) |
| 3 years |
50(66.6%) |
90(80.4%) |
27(48.2%) |
| 5 years |
35(38.8%) |
67(60%) |
6(10.7%) |
Table 2: Oncological outcome after radical cystectomy for muscle invasive carcinoma of the bladder in three histologic variant. Recurrence, metastases, and overall survival in 5 years follow up